The committee voted 9-5 to recommend two different RSV vaccines for adults ages 65 and up.
that showed that a single dose lowered the risk of symptomatic illness by 83% and of severe illness by 94%.in which it reduced the risk of symptomatic illness by as much as 86%. More recent data presented Wednesday to the CDC showed that protection waned slightly by around 18 months after vaccination, though it was still as high as 79%.
In evaluating the safety of Pfizer's vaccine, the FDA identified one case of Guillain-Barré syndrome, a rare neurological disorder, and one case of Miller Fisher syndrome, a rare nerve disease related to Guillain-Barré.of Guillain-Barré that was potentially related to GSK’s vaccine, as well as a higher number of incidences of atrial fibrillation among vaccine recipients relative to the trial's control group.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and olderThe CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
Read more »
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSVA panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections be available to older adults in the U.S. but stopped short of saying all of them should get the shots.
Read more »
Pfizer RSV vaccine for older adults is only slightly less effective after 18 monthsPfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.
Read more »
Pfizer RSV vaccine for older adults is slightly less effective after 18 monthsPfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.
Read more »
Next Vaccine You Should Get? Health Advisers May Recommend RSV ShotsGSK and Pfizer RSV vaccines were approved earlier this year by the FDA for adults aged 60 and older.
Read more »
Next Vaccine You Should Get? U.S. Health Advisers Back RSV ShotsThe first RSV vaccines for older adults took a big step toward widespread availability on Wednesday, when experts advising the U.S. government backed the new shots for adults 60 years and older
Read more »